80 related articles for article (PubMed ID: 18177475)
1. Chiral separation of racemate CPU86017, an anti-arrhythmic agent, produces stereoisomers possessing favourable ion channel blockade and less alpha-adrenoceptor antagonism.
Li N; Yang L; Dai DZ; Wang QJ; Dai Y
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):643-50. PubMed ID: 18177475
[TBL] [Abstract][Full Text] [Related]
2. CPU86017: a novel Class III antiarrhythmic agent with multiple actions at ion channels.
Dai DZ
Cardiovasc Drug Rev; 2006; 24(2):101-15. PubMed ID: 16961724
[TBL] [Abstract][Full Text] [Related]
3. Blockade of L-type calcium channel in myocardium and calcium-induced contractions of vascular smooth muscle by CPU 86017.
Dai DZ; Hu HJ; Zhao J; Hao XM; Yang DM; Zhou PA; Wu CH
Acta Pharmacol Sin; 2004 Apr; 25(4):416-23. PubMed ID: 15066206
[TBL] [Abstract][Full Text] [Related]
4. CPU86017 and its isomers improve hypoxic pulmonary hypertension by attenuating increased ETA receptor expression and extracellular matrix accumulation.
Li N; Dai DZ; Dai Y
Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):541-52. PubMed ID: 18548232
[TBL] [Abstract][Full Text] [Related]
5. Effects of benzyltetrahydropalmatine on potassium currents in guinea pig and rat ventricular myocytes.
Li Y; Fu LY; Yao WX; Xia GJ; Jiang MX
Acta Pharmacol Sin; 2002 Jul; 23(7):612-6. PubMed ID: 12100754
[TBL] [Abstract][Full Text] [Related]
6. Induced ion currents and the endothelin pathway as targets for anti-arrhythmic agents.
Dai DZ; Dai Y
Curr Opin Investig Drugs; 2008 Sep; 9(9):1001-8. PubMed ID: 18729007
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of DDPH on two components of delayed rectifier potassium current in guinea pig ventricular cells.
Zhong N; Fang QZ; Zhang Y; Xia JS; Qian JQ; Zhou ZN
Acta Pharmacol Sin; 2002 Jul; 23(7):601-8. PubMed ID: 12100752
[TBL] [Abstract][Full Text] [Related]
8. Molecular hybridization, synthesis, and biological evaluation of novel chroman I(Kr) and I(Ks) dual blockers.
Du L; Li M; Yang Q; Tang Y; You Q; Xia L
Bioorg Med Chem Lett; 2009 Mar; 19(5):1477-80. PubMed ID: 19185489
[TBL] [Abstract][Full Text] [Related]
9. Abrupt changes in FKBP12.6 and SERCA2a expression contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017.
Na T; Huang ZJ; Dai DZ; Zhang Y; Dai Y
Acta Pharmacol Sin; 2007 Jun; 28(6):773-82. PubMed ID: 17506935
[TBL] [Abstract][Full Text] [Related]
10. Role of endothelin in the effects of isoprenaline on potassium currents and calsequestrin 2 expression in the heart.
Li N; Jia N; Dai DZ; Hu C; Dai Y
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):557-63. PubMed ID: 20529095
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of voltage-gated L-type calcium channels by labedipinedilol-A involves protein kinase C in rat cerebrovascular smooth muscle cells.
Wu BN; Chen ML; Dai ZK; Lin YL; Yeh JL; Wu JR; Chen IJ
Vascul Pharmacol; 2009; 51(2-3):65-71. PubMed ID: 19298869
[TBL] [Abstract][Full Text] [Related]
12. Dispersion of ventricular mRNA of RyR2 and SERCA2 associated with arrhythmogenesis in rats.
Wang HL; Dai DZ; Gao E; Zhang YP; Lu F
Acta Pharmacol Sin; 2004 Jun; 25(6):738-43. PubMed ID: 15169625
[TBL] [Abstract][Full Text] [Related]
13. Effects of (S)-amlodipine and (R)-amlodipine on L-type calcium channel current of rat ventricular myocytes and cytosolic calcium of aortic smooth muscle cells.
Wang RX; Jiang WP; Li XR; Lai LH
Pharmazie; 2008 Jun; 63(6):470-4. PubMed ID: 18604992
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory factors that contribute to upregulation of ERG and cardiac arrhythmias are suppressed by CPU86017, a class III antiarrhythmic agent.
Du RH; Yi HW; Dai DZ; Tang WH; Dai Y
J Pharm Pharmacol; 2008 Aug; 60(8):1089-95. PubMed ID: 18644201
[TBL] [Abstract][Full Text] [Related]
15. Cellular mechanism of the QT prolongation induced by sulpiride.
Lee HA; Kim KS; Park SJ; Kim EJ
Int J Toxicol; 2009; 28(3):207-12. PubMed ID: 19546258
[TBL] [Abstract][Full Text] [Related]
16. The effects of quinidine and its chiral isolates on erg-1sm potassium current and correlation with gastrointestinal augmentation.
Cvetanovic I; Lin C; Ranade V; Keshavarzian A; Somberg J
Am J Ther; 2007; 14(3):269-76. PubMed ID: 17515703
[TBL] [Abstract][Full Text] [Related]
17. In silico risk assessment for drug-induction of cardiac arrhythmia.
Suzuki S; Murakami S; Tsujimae K; Findlay I; Kurachi Y
Prog Biophys Mol Biol; 2008 Sep; 98(1):52-60. PubMed ID: 18635251
[TBL] [Abstract][Full Text] [Related]
18. Interaction of alpha1-adrenoceptor subtypes with different G proteins induces opposite effects on cardiac L-type Ca2+ channel.
O-Uchi J; Sasaki H; Morimoto S; Kusakari Y; Shinji H; Obata T; Hongo K; Komukai K; Kurihara S
Circ Res; 2008 Jun; 102(11):1378-88. PubMed ID: 18467629
[TBL] [Abstract][Full Text] [Related]
19. hERG1 channel activators: a new anti-arrhythmic principle.
Grunnet M; Hansen RS; Olesen SP
Prog Biophys Mol Biol; 2008; 98(2-3):347-62. PubMed ID: 19351523
[TBL] [Abstract][Full Text] [Related]
20. CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity.
Qi MY; Feng Y; Dai DZ; Li N; Cheng YS; Dai Y
Acta Pharmacol Sin; 2010 Feb; 31(2):165-74. PubMed ID: 20139899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
